Basilia Zingarelli, Cincinnati Childrens Hospital Medical Center, United States Updates Copyright 2023 Mehdi, Pusapati, Anwar, Lohana, Kumar, Nandula, Nawaz, Tracey, Yang, LeRoith, Brownstein and Roth
The slightly immunocompromised condition of G6PD-deficient patients may prevent severe inflammation, which may be consequently beneficial to patients
What is the mechanism of action of retatrutide?
In the last few years, different targeted therapies against pro-inflammatory cytokines in CVD were tested, but with no outstanding results
Researchers are investigating whether combining GIP activity with GLP-1 activity can produce a broader metabolic response than targeting GLP-1 alone